1 results match your criteria: "Endocrinology and Metabolism University of Oxford Oxford UK.[Affiliation]"
Progression of glucose-lowering diabetes therapy in TECOS.
Endocrinol Diabetes Metab
January 2019
Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism University of Oxford Oxford UK.
Aims: TECOS was a randomized, double-blind, placebo-controlled trial assessing the impact of sitagliptin vs. placebo on cardiovascular outcomes when added to usual care in patients with type 2 diabetes. We report the use of concomitant diabetes medications and the risk for progression to insulin during follow-up.
View Article and Find Full Text PDF